US EditionPublished • loading... • Updated
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO awarded a stock option for 24,000 shares to a new employee under its 2022 Inducement Plan with a $2.06 exercise price, vesting over three years.
- On Dec. 19, 2025, INOVIO announced an equity grant to a newly hired employee for an option to purchase 24,000 shares with a November 28, 2025 Grant Date.
- Compensation Committee of INOVIO's Board of Directors approved the award under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635, the press release said.
- Exercise price equals $2.06, the Grant Date November 28, 2025 closing price, and the option vests over three years with one-third on each anniversary, conditioned on continued employment.
- Media and investor contact details were provided in the release, listing Jennie Willson, media contact, and directing readers to www.inovio.com for more information.
- INOVIO is a biotechnology company developing DNA medicines that teach the body to manufacture its own disease‑fighting tools, focusing on HPV-related diseases, cancer and infectious diseases.
Insights by Ground AI
37 Articles
37 Articles
The Berkshire Eagle+36 Reposted by 36 other sources
INOVIO Reports Inducement Grant Under Inducement Plan
PLYMOUTH MEETING, Pa., Dec. 19, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made…
Coverage Details
Total News Sources37
Leaning Left3Leaning Right3Center11Last UpdatedBias Distribution65% Center
Bias Distribution
- 65% of the sources are Center
65% Center
L 18%
C 65%
R 17%
Factuality
To view factuality data please Upgrade to Premium
